Alex Biese

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Learn about inflammatory breast cancer (IBC) diagnosis, aggressive treatment paths, and side effects to better navigate your journey and care plan.

The 49th Annual Miami Breast Cancer Conference recently hosted a cornerstone event for the advocacy community: the CURE Educated Patient® Breast Cancer Summit.

Learn about Ductal Carcinoma in Situ (DCIS), its diagnosis, treatment options and side effects. Empower yourself with information to navigate this journey with confidence.

New NCCN guidelines highlight how structured exercise and molecular profiling significantly reduce recurrence rates.

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation.

The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in disease progression risk.

Dr. Joseph Mikhael, chief medical officer of the International Myeloma Foundation, provided updates from the front lines of treatment advancement.

A comprehensive guide to medullary thyroid cancer (MTC), covering symptoms, RET genetic testing, surgical options and advanced targeted therapies.

A community study finds Enhertu effective for HER2-low mBC, with over half of patients seeing tumor shrinkage and high one-year survival rates.

New data show more women over 70 are safely skipping sentinel lymph node biopsies for HR+ breast cancer, reducing unnecessary surgery and risks.

Learn how survivor Julie Cohen navigated high-risk multiple myeloma, failed treatments and the vital role of nurse navigators in chronic cancer care.

CURE spoke with incoming ASCO president Dr. Deb Schrag on elevating the patient voice, humanism in care and why partnership shapes better cancer outcomes.

MGUS is a precursor condition that requires monitoring rather than aggressive intervention.

Learn about Kaposi sarcoma causes, symptoms and the latest treatment options to help you navigate your diagnosis and talk with your oncologist.

Dr. Sara Tolaney discusses how Trodelvy plus Keytruda improves progression-free survival in patients with PD-L1+ metastatic triple-negative breast cancer.

Researchers identified nine genetic markers that help HER2-positive breast cancer resist treatment, paving the way for more personalized patient care.

For many patients with cancer, it is never too soon to begin discussing fertility preservation options as they begin their cancer journeys.

A comprehensive guide for newly diagnosed patients with follicular thyroid cancer.

Exploring the importance of heart health in cancer survivorship, we spoke with experts and survivors.

CURE spoke with breast cancer survivor Mary Royal about her cancer journey in a multipart interview.

Merkel cell carcinoma is a rare and aggressive form of neuroendocrine skin cancer. While it accounts for a small fraction of all skin cancer cases, its impact is significant.

CURE sat down with Dr. Kathie-Ann Joseph to discuss surgical advancements for individuals with breast cancer.

Oral KTX-1001 achieved 40% disease control in phase 1 trials, offering a new targeted therapy for aggressive t(4;14) translocation multiple myeloma.

Smoldering multiple myeloma is a complex, intermediary stage of plasma cell disorders that requires a nuanced approach to care.

Dr. Anne Peled, a two-time breast cancer survivor, underwent a sensation-preserving mastectomy, a procedure she co-developed.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

Among patients with advanced breast cancer, levels of circulating tumor DNA before treatment may predict their response to targeted therapy.

Researchers sought to address a critical gap in the health care system where 85% of U.S. children diagnosed with cancer survive at least five years.

Receiving a diagnosis of squamous cell carcinoma can be an overwhelming experience, but it is important to remember that you are not alone.